Stimulation of host defense mechanisms against tumors

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 855, 424 856, 424 857, 424 111, 4242781, 514 2, 530351, A61K 3821, C07K 14555, C07K 1456, C07K 1457

Patent

active

059978589

ABSTRACT:
A method for treating neoplastic disease in a mammal via administering to the mammal a therapeutically effective amount of an interferon via oromucosal contact. The amount of interferon administered is less than an amount which induces a pathological response when administered parenterally.

REFERENCES:
patent: 4605555 (1986-08-01), Sato et al.
patent: 5017371 (1991-05-01), Cummins
patent: 5019382 (1991-05-01), Cummins, Jr.
patent: 5286748 (1994-02-01), Eby, III
Kiskis, J. Interferon Cytokine Res. 15 Supplls 184, 1995 (abstract).
Gutterman, PNAS 91:1198, 1994.
Bocci, Crit Rev. Ther Drug Carrier Syst 9(2):91-133, 1992 (abstract).
Babiuch, Archivum Immunologiae et Therapiae Experimentalis 41(3-4):213-219, 1993 (abstract only).
Caban, Archivom Immunologiae et Therapiae Experimentalis 41(3-4) 1993 pp. 229-235 (abstract only).
Hayden, Frederick G., "Intranasal Interferon .alpha.2 for Prevention of Rhinovirus Infection and Illness", The Journal of Infectious Diseases, vol. 148, No. 3 Sep. 1983. pp. 543-550.
Hayden et al., "Human Tolerance Histopathologic Effects of Long Term Administration of Intranasal Interferon-.alpha.2", Journal of Infectious Diseases 148:914-921 (1983).
Hayden et al., "Human Nasal Mucosal Responses to Topically Applied Recombinant Leukocyte A Interferon", Journal of Infectious Diseases 156:64-72 (1987).
Machida et al., "Absorption of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) from Rat Nasal Mucosa", Pharmaceutical Research 10:1372-1377 (1993).
Samo et al., "Efficacy and Tolerance of Intranasally Applied Recombinant Leukocyte A Interferon in Normal Volunteers", Journal of Infectious Diseases 148:535-542 (1983).
Samo et al., "Intranasally Applied Recombinant Leukocyte A Interferon in Normal Volunteers. II.", Journal of Infectious Diseases 150:181-188 (1984).
Takeda et al., "Pharmacological Activity of Tablets Containing Recombinant Human Granulocyte . . . ", International Journal of Pharmaceutics 101:89-96 (1994).
Watanabe et al., "Absorption and Blood Leukocyte Dynamics of Recombinant Human Granulocyte Colony-Stimulating Factor . . . ", International Journal of Pharmaceutics 110:93-97 (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Stimulation of host defense mechanisms against tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stimulation of host defense mechanisms against tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stimulation of host defense mechanisms against tumors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-820537

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.